STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma

Published:2018-03 Issue: Volume:10 Page:398-411
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Esposito Carla Lucia,Nuzzo Silvia,Catuogno Silvia,Romano Simona,de Nigris Filomena,de Franciscis Vittorio

Funder

AIRC

CNR Flagship Project NanoMax

Italian Ministry of Health

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference55 articles.

1. The 2016 World Health Organization classification of tumors of the central nervous system: a summary;Louis;Acta Neuropathol.,2016

2. International Society of Neuropathology—Haarlem consensus guidelines for nervous system tumor classification and grading;Louis;Brain Pathol.,2014

3. Signaling determinants of glioma cell invasion;Kwiatkowska;Adv. Exp. Med. Biol.,2013

4. Implications of Rho GTPase signaling in glioma cell invasion and tumor progression;Fortin Ensign;Front. Oncol.,2013

5. Class III beta-tubulin and gamma-tubulin are co-expressed and form complexes in human glioblastoma cells;Katsetos;Neurochem. Res.,2007

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspective Chapter: Mastering RNA Interference (RNAi) Delivery – Strategies for Effective Targeting and Gene Silencing;Beyond the Blueprint - Decoding the Elegance of Gene Expression [Working Title];2024-07-12

2. Aptamers: ushering in new hopes in targeted glioblastoma therapy;Journal of Drug Targeting;2024-07-03

3. Nucleolin-Targeting AS1411 Aptamer-Conjugated Nanospheres for Targeted Treatment of Glioblastoma;Pharmaceutics;2024-04-21

4. Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics;Cancers;2024-01-24

5. Tools and techniques for the discovery of therapeutic aptamers: recent advances;Expert Opinion on Drug Discovery;2023-10-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3